---
title: "CITIC International has raised the target price for HENLIUS to RMB 61.98, expecting significant potential in innovative drug development"
description: "CMB International raised the target price of HENLIUS from RMB 20.33 to RMB 61.98, maintaining a \"Buy\" rating. The report pointed out that HENLIUS has the potential to develop from a biosimilar company"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/246006212.md"
published_at: "2025-06-25T03:13:22.000Z"
---

# CITIC International has raised the target price for HENLIUS to RMB 61.98, expecting significant potential in innovative drug development

> CMB International raised the target price of HENLIUS from RMB 20.33 to RMB 61.98, maintaining a "Buy" rating. The report pointed out that HENLIUS has the potential to develop from a biosimilar company into a leading enterprise in the biopharmaceutical field, with promising performance of its innovative drugs under development and expansion of global business through partnerships with pharmaceutical companies. The market authorization applications for HLX14 and HLX11 are under FDA review and are expected to bring overseas revenue to the company

Zhao Yin International published a research report stating that HENLIUS (02696.HK) has the capability to develop from a profitable biosimilar company into a leading enterprise in the biopharmaceutical field. Several innovative drugs under development, including HLX43, HLX22, and Serplulimab, have shown good clinical data performance. The report believes in the company's substantial growth potential, thus raising the target price from HKD 20.33 to HKD 61.98, maintaining a "Buy" rating.

Zhao Yin International believes that HENLIUS is actively expanding its global biosimilar business through collaborations with pharmaceutical companies. Its products "Hanquyou" (Trastuzumab) and Serplulimab have shown strong commercialization performance, while the marketing authorization applications for HLX14 and HLX11 are currently under FDA review, which is expected to open up overseas revenue sources

### Related Stocks

- [02696.HK - HENLIUS](https://longbridge.com/en/quote/02696.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 馬克宏訪印度 著眼百餘架飆風戰機軍售大單 | 法國總統馬克宏將於 17 日至 19 日訪問印度，重點討論人工智慧合作及達梭飆風戰機的採購，預計將討論增購 114 架戰機的合約。此次訪問是馬克宏自 2017 年上任以來的第四次，期間他將與印度總理莫迪會晤，並參加人工智慧高峰會。印度已於  | [Link](https://longbridge.com/en/news/276113483.md) |
| 馬克宏訪印度 聚焦 AI 合作、飆風戰機訂單 | 法國總統馬克宏在印度進行為期三天的訪問，重點關注人工智慧合作及 114 架飆風戰機的訂單，價值約 300 億歐元。此次訪問是馬克宏自 2017 年上任以來的第四次，旨在加強與印度的軍事夥伴關係。印度國防部已批准採購提案，絕大部分戰機將在印度 | [Link](https://longbridge.com/en/news/276160221.md) |
| U2 發佈了歌曲《American Obituary》，以向 Renee Good 致敬 | U2 發佈了一首名為《American Obituary》的歌曲，以此向在明尼阿波利斯被 ICE 官員殺害的母親 Renee Good 致敬。這首歌是他們 EP《U2 Days of Ash》的一部分，歌詞反映了她的去世及其對美國的更廣泛影 | [Link](https://longbridge.com/en/news/276275369.md) |
| 據《電訊報》報道，英國警方抵達了查爾斯國王的兄弟安德魯的住所 | 英國警方抵達查爾斯國王的兄弟安德魯·蒙巴頓 - 温莎的住所，因有指控稱他向傑弗裏·愛潑斯坦泄露了機密文件。在桑德林漢姆莊園的伍德農場，目擊者看到六輛無標記的警車和八名便衣警察。蒙巴頓 - 温莎否認有不當行為，並對與愛潑斯坦的友誼表示遺憾，但 | [Link](https://longbridge.com/en/news/276319933.md) |
| 優必選機器人召集三月股東特別大會以批准收購浙江鋒龍電氣 43% 的股份 | 優必選機器人有限公司已定於 2026 年 3 月 10 日在深圳召開臨時股東大會，以尋求股東批准收購浙江鋒龍電氣有限公司 43% 的股份。此次收購旨在增強優必選在科技和電氣領域的業務範圍。會議將概述股東資格和程序要求。目前，該股票的評級為賣 | [Link](https://longbridge.com/en/news/276118745.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.